On April 25, 2019, the Board of Directors of Avanos Medical, Inc. appointed Warren J. Machan to serve as Interim Chief Financial Officer, effective May 8, 2019, with responsibility for the Company’s global finance, accounting, and business services groups, including IT. Mr. Machan will, on an interim basis, succeed Mr. Steven Voskuil, who, as previously disclosed, notified the Company of his resignation, also effective May 8, 2019. The Company has already commenced a search for a new, permanent Chief Financial Officer. While Mr. Machan is the Interim Chief Financial Officer, he will also retain his previous title and responsibilities as Senior Vice President - Business Strategy, a position he has held since spun-off from Kimberly-Clark Corporation on October 31, 2014. Prior to joining the Company, Mr. Machan was an employee of Kimberly-Clark for more than 25 years, primarily in finance roles. He served as Senior Director of Strategy for their Health Care business from January 2012 until spin-off in October 2014.
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. The Companyâs acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
AVANOS MEDICAL, INC. 
